INVESTIGATION: “Trans” ideology pushed by Big Pharma and surgery companies backed by $400 million P.R. campaign

pharma-money1

(Natural News) Over the years, Natural Newshas drawn attention to certain environmental factors that are having a profound gender-bending effect on both human and animal life. But don’t for a second think that this onslaught is an unintended consequence of big industry; as new reports suggest, that this was all pre-planned as a way for Big Pharma to rake in more profits.

Much of it is tied into the push for acceptance and normalization of transgenderism, which New York-based feminist Jenifer Bilek admits is a conspiracy, of sorts, to funnel money towards certain special interests groups. Among these are drug companies that supply hormones and other chemical concoctions that aid the process of gender “conversion,” as well as surgery companies and other key players in the healthcare industry.

More than $400 million, she says, has been given by donors and business groups to promote the transgender agenda, which really gained traction during the latter years of the Obama regime. Pro-transgender funding isn’t often talked about, but it’s speaking volumes in the background, greasing the wheels of more profit flow for those also pushing more drugs and surgery for profit on the masses.

This is why questioning gender-trumps-biology dogma has almost become a prosecutable offense in politically-correct America, where stating facts about human nature is no longer accepted. It’s also why those in charge of the narrative are pushing so hard for anything-goes bathrooms, showers, and locker rooms, as normalization of such perversion is the key to ensuring that Big Pharma obtains the profits it so desperately craves.

“These men and others, including pharmaceutical companies and the U.S. government, are sending millions of dollars to LGBT causes,” Bilek writes, noting that many doctors, reporters, researchers, and surgeons are too afraid to stand against this evil agenda.

“Overall reported global spending on LGBT is now estimated at $424 million,” she adds. “From 2003-2013, reported funding for transgender issues increased more than eightfold, growing at threefold the increase of LGBTQ funding overall, which quadrupled from 2003 to 2012. This huge spike in funding happened at the same time transgenderism began gaining traction in American culture.”

Victims of transgender programming receive little, or none, of this money

What’s perhaps even more disturbing are the victims of this evil campaign who’ve succumbed to the programming and undergone surgeries or hormone therapies in a futile attempt to change their genders. The LGBT mafia loves to pretend as though it raises funds to help these people, but as Bilek reports, very little – if any – of this money ends up in a place where it helps LGBT victims.

Virtually all of it, she says, goes towards government agencies, technology think tanks, and pharmaceutical corporations that are pushing an agenda. And that agenda is to institutionalize and normalize transgenderism as a “lifestyle choice,” as Bilek puts it.

“They are shaping the narrative about transgenderism and normalizing it within the culture using their funding methods,” she points out.

“[Promoting] Bodily diversity appears to be the core issue, not [treating] gender dysphoria; that and unmooring people from their biology via language distortions, to normalize altering human biology. Institutionalizing transgender ideology does just this. This ideology is being promoted as a civil rights issue by wealthy, white men with enormous influence who stand to personally benefit from their political activities.”

This is important to keep in mind the next time somebody tries to tell you that transgenderism is normal, and that the mass “coming out” of people in recent years is just an organic outpouring of people believing they finally have the freedom to “be themselves.” In reality, these people have been brainwashed by a massive social engineering experiment that, likes most other things in life, is being driven by greed and Big Pharma money-lust. (Click to Source)

CLICK HERE or the finest faith based personalized and compassionate addiction recovery program – right from the comfort of your home.

This company reinvented vitamins! Use my referral link to get $30 off your first purchase . CLICK HERE for your discount.

Maker of highly addictive OxyContin says it will stop incentivizing doctors to push its deadly drugs

prescription-drug-addiction-eating-opioids-e1518776407521

(Natural News) The opioid crisis has reached epidemic proportions in this country, with the number of deaths quadrupling since 2000, and around 115 people dying from overdoses each day. President Trump has declared the opioid crisis a national health emergency, and high schools across the country have started stocking up on the drug Narcan to try to save lives in case of an accidental overdose on school premises.

The Centers for Disease Control and Prevention (CDC) estimates that when you consider direct healthcare costs, lost productivity, criminal prosecution and addiction treatment, this crisis costs the United States around $78.5 billion annually.

Now, Big Pharma giant Purdue, the  manufacturer of OxyContin, the world’s bestselling opioid drug, has vowed to stop marketing the drug to healthcare professionals.

Several pharmaceutical manufacturers, including Purdue, have admitted to having entire teams of sales people, as well as “front groups” and “key opinion leaders,” pushing the drug as a mainstream option for chronic, long-term pain, even though the drug was designed for cancer patients and others suffering severe pain who only need pain relief for a limited period of time.

As reported by Circa, when the drug was first released in 1995, it was hailed as a breakthrough in the treatment of severe pain, but users quickly learned that they could abuse the drug to get a high:

It worked over 12 hours to maintain a steady level of oxycodone in patients suffering from a wide range of pain ailments. But some users quickly discovered they could get a heroin-like high by crushing the pills and snorting or injecting the entire dose at once. In 2010 Purdue reformulated OxyContin to make it harder to crush and stopped selling the original form of the drug.

The manufacturer did not discontinue making the drug, of course, and went on to pitch it to healthcare professionals as a low-risk wonder drug for the treatment of pain. Purdue also later admitted to minimizing the addiction risk to doctors, who went on to prescribe it for many off-label uses, directly resulting in the crisis the country is now faced with. (Related: Learn more about what caused this crisis and what is being done to cope with it at Opioids.news.)

In the meantime, Purdue has been raking in billions in profits each year.

It is unlikely that the company has altruistic reasons for agreeing to stop lying to doctors about the risks and benefits of OxyContin. It is far more likely that the multiple lawsuits it has been inundated with has led to this change of heart.

While it is certainly better that Purdue is now no longer going to pitch propaganda to the healthcare community and has halved its sales staff to that end, experts believe that other pharmaceutical companies will have to follow suit before any real progress can be made in turning the tide of the opioid crisis.

“It is difficult to promote more cautious prescribing to the medical community because opioid manufacturers promote opioid use,” said Dr. Andrew Kolodny, director of opioid policy research at Brandeis University, and expert adviser in several of the lawsuits pending against Big Pharma.

While Purdue is a major producer of opioids, other big players like Johnson & Johnson and Allergan would have to make the same commitment to stopping the propaganda machine for any real progress to be made. (Related: Didn’t they take an oath not to do harm? Opioids are coming from doctors’ offices, not the ER.)

And while Purdue has promised to make changes in the U.S., it is making no such commitment regarding the international market.

“They are still doing this abroad,” Kolodny noted. “They are following the same playbook that they used in the United States.”

Circa noted that while Purdue Pharma only operates under that name in the United States, it is associated with two other pharmaceutical companies, Mundipharma and Napp, overseas. Purdue has distanced itself from these producers, saying that they operate independently and according to local regulations.

So, no real change of heart, then. They’ve simply turned their attention to the next lucrative market. (Click to Source)

CLICK HERE or the finest faith based personalized and compassionate addiction recovery program – right from the comfort of your home.